Search results
Eli Lilly's Migraine Candidate Flunks Head-To-Head Study With Pfizer's Newly Acquired Drug
Benzinga via Yahoo Finance· 11 months agoEli Lilly And Co (NYSE: LLY) announced the results of the CHALLENGE-MIG clinical trial of Emgality...
Lilly's (LLY) Migraine Drug Fails Vis-a-Vis Pfizer's Nurtec ODT
Zacks via Yahoo Finance· 11 months agoResults from a post-approval study show that treatment with Lilly's (LLY) Emgality failed to achieve...
Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial
Reuters via Yahoo Finance· 2 years agoEli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to...
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters via Yahoo Finance· 7 months agoDrugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5...
Eli Lilly's migraine drug fails to prove superiority to Pfizer's
Reuters via Yahoo News· 11 months agoThe three-month study, which involved 580 patients, was the first-of-its-kind to compare the two...
Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 7 months agoEli Lilly & Company LLY will report third-quarter 2023 results on Nov 2, before market open. In the...
One Woman Shares How She Found Some Migraine Relief – After Experiencing the Debilitating Disease...
SheKnows via Yahoo News· 4 months agoAmanda, a 35-year-old mother, outdoor enthusiast and electrical engineer, will always remember May...
Eli Lilly (LLY) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Eli Lilly & Company LLY to beat expectations when it reports first-quarter 2023 results on...
Eli Lilly (LLY) Q2 Earnings Beat, Mounjaro Powers Sales Growth
Zacks via Yahoo Finance· 9 months agoEli Lilly and Company LLY reported second-quarter 2023 adjusted earnings per share of $2.11, which...
Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 2 months agoA month has gone by since the last earnings report for Eli Lilly (LLY). Shares have added about 7.5%...